Glycan-based antibody-drug conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11332544
APP PUB NO 20170362338A1
SERIAL NO

15493720

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Genetically engineered antibodies containing non-native N-glycosylated sites, preparation of the antibodies in yeast and fungi, site-specific conjugation of drugs to these antibodies, and methods of treatment utilizing these antibodies are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MERCK SHARP & DOHME CORP.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davidson, Robert Enfield, US 75 597
Gong, Bing North Reading, US 37 101

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 17, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 17, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 17, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00